Physician profile
David Solarte
NPI 1538222401
$799.75
in general payments reported to CMS, 2019-2025
7 companies · $381 in 2025
The $381 reported for 2025 was more than what 89% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.14 · 2020: $27.89 · 2022: $120 · 2023: $48.40 · 2024: $136 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $530.75 | 2020-2025 | Arexvy, Shingrix, Bexsero |
| Amgen INC. | $120.16 | 2022 | |
| Sanofi Pasteur INC. | $63.45 | 2019-2023 | |
| Dynavax Technologies Corporation | $32.86 | 2019 | |
| Abbvie INC. | $22.20 | 2023 | Ubrelvy |
| Merck Sharp & Dohme LLC | $16.03 | 2019 | |
| Phadia US INC. | $14.30 | 2024 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Solarte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.